David Cordani - Feb 23, 2022 Form 4 Insider Report for Cigna Corp (CI)

Role
Chair, President & CEO, Director
Signature
By: Jill M. Stadelman, attorney-in-fact
Stock symbol
CI
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 07:48 PM
Previous filing
Nov 30, 2021
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +12.8K +9.13% $0.00 153K Feb 23, 2022 Direct F1, F2
holding CI Common Stock, $.01 Par Value 1.67K Feb 23, 2022 By 401(k) F3
holding CI Common Stock, $.01 Par Value 371K Feb 23, 2022 By GRAT F2
holding CI Common Stock, $.01 Par Value 39.8K Feb 23, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +57.3K $0.00 57.3K Feb 23, 2022 Common Stock, $.01 Par Value 57.3K $227.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2023.
F2 Reflects the transfer by the Reporting Person of 238,430 shares of common stock to a grantor retained annuity trust on November 18, 2021 and the transfer by the Reporting Person's grantor retained annuity trust of 104,736 shares of common stock in respect of the payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust on January 10, 2022.
F3 Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F4 This option vests in three equal annual installments beginning March 1, 2023.